Merck, GE, IBM collaborate on vaccine plant

Plans are coming together for a major vaccine manufacturing plant intended for quick response to biological, chemical and radiological attacks. The University of Pittsburgh Medical Center envisions an academia-industry-government collaboration, and it's drawing in some big names.

Merck will provide drug development and bioprocess counsel in a planned consortium of biopharmas. R&D giant Battelle will provide pre-clinical research, as well as model development for infectious diseases and for evaluations of product safety and efficacy. Battelle's services extend to the licensing of vaccines and therapeutics. IT will be provided by IBM.

These big guns join GE Healthcare, already at work with UPMC, which sees the venture as a federally funded non-profit subsidiary.

- here's the article

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.